CompletedNCT00442039
Lithium for mania in children with bipolarity
About this title
Read the official source — NCT00442039Medication studyAges 7–17United States
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateDecember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 61
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT00442039
- Official title
Show the full official title
Pediatric Pharmacokinetic and Tolerability Study of Lithium for the Treatment of Pediatric Mania Followed by an Open Label Long Term Safety Period, Discontinuation Phase, and Restabilization Period.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Lithium Carbonate and Placebo.
Who was this study for?
Listed age limits: 7 years to 17 years.
